探索診斷DGX
紐約證券 · USD
170.85
+3.44
(+2.05%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
探索診斷DGX
170.85
+3.44
(+2.05%)
財務數據
損益表
- 23.31
- 23.38
- 22.95
- 22.88
- 23.66
- 23.97
- 24.88
- 26.21
- 26.52
- 27.61
- -0.09
- 0.30
- -1.84
- -0.31
- 3.41
- 1.31
- 3.80
- 5.35
- 1.18
- 4.11
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 2,761,000 | 2,652,000 | 2,621,000 | 2,488,000 | 2,397,000 | 2,366,000 | 2,288,000 | 2,295,000 | 2,338,000 | 2,331,000 |
營業成本 | 1,818,000 | 1,789,000 | 1,763,000 | 1,677,000 | 1,593,000 | 1,595,000 | 1,552,000 | 1,541,000 | 1,546,000 | 1,560,000 |
營業毛利 | 943,000 | 863,000 | 858,000 | 811,000 | 804,000 | 771,000 | 736,000 | 754,000 | 792,000 | 771,000 |
營業費用 | 505,000 | - | - | - | - | 471,000 | 469,000 | 412,000 | 444,000 | 466,000 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 486,000 | 478,000 | 460,000 | 449,000 | 420,000 | 442,000 | 442,000 | 385,000 | 416,000 | 440,000 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | -20,000 | 39,000 | 37,000 | 32,000 | 29,000 | 29,000 | 27,000 | 27,000 | 28,000 | 26,000 |
營業利益 | 438,000 | 346,000 | 361,000 | 330,000 | 355,000 | 300,000 | 267,000 | 342,000 | 348,000 | 305,000 |
其他收入及費用 | - | -3,000 | 3,000 | 15,000 | 3,000 | 9,000 | 10,000 | -3,000 | 6,000 | 7,000 |
利息費用 | 69,000 | 67,000 | 65,000 | 49,000 | 44,000 | 43,000 | 40,000 | 40,000 | 37,000 | 35,000 |
稅前純益 | 384,000 | 276,000 | 299,000 | 296,000 | 314,000 | 266,000 | 237,000 | 299,000 | 317,000 | 277,000 |
所得稅 | 97,000 | 59,000 | 68,000 | 65,000 | 74,000 | 66,000 | 40,000 | 68,000 | 75,000 | 65,000 |
稅後純益 | 282,000 | 220,000 | 222,000 | 226,000 | 229,000 | 194,000 | 192,000 | 225,000 | 235,000 | 202,000 |
基本每股稅後盈餘(元) | 2.51 | 1.97 | 1.98 | 2.01 | 2.05 | 1.74 | 1.72 | 1.99 | 2.08 | 1.80 |
稀釋每股稅後盈餘(元) | 2.47 | 1.94 | 1.95 | 1.99 | 2.03 | 1.72 | 1.70 | 1.96 | 2.05 | 1.78 |
基本平均股數(千股) | 112000.00 | 111000.00 | 111000.00 | 112000.00 | 111000.00 | 111000.00 | 112000.00 | 112000.00 | 112000.00 | 112000.00 |
稀釋平均股數(千股) | 113000.00 | 113000.00 | 113000.00 | 113000.00 | 112000.00 | 112000.00 | 113000.00 | 114000.00 | 114000.00 | 113000.00 |
還原基本每股稅後盈餘(元) | 2.51 | 1.97 | 1.98 | 2.01 | 2.05 | 1.74 | 1.72 | 1.99 | 2.08 | 1.80 |
還原稀釋每股稅後盈餘(元) | 2.47 | 1.94 | 1.95 | 1.99 | 2.03 | 1.72 | 1.70 | 1.96 | 2.05 | 1.78 |
還原基本平均股數(千股) | 112,000 | 111,000 | 111,000 | 112,000 | 111,000 | 111,000 | 112,000 | 112,000 | 112,000 | 112,000 |
還原稀釋平均股數(千股) | 113,000 | 113,000 | 113,000 | 113,000 | 112,000 | 112,000 | 113,000 | 114,000 | 114,000 | 113,000 |
EBITDA(千元) | 591,000 | 486,000 | 490,000 | 465,000 | 464,000 | 419,000 | 381,000 | 444,000 | 459,000 | 409,000 |